Sai Life Sciences Sustainability Report 2020

10 Key performance highlights Since our establishment over two decades ago, starting out as a small laboratory, we have come a long way in our quest to bring new medicines to life. Today, we are one of the fastest growing CDMOs in India, backed by committed investors TPG Capital and HBM Partners. We have been making significant investments to address the growing demand from innovator companies globally. 100+ 25+ clinical stage programs served. programs advanced from IND to phase I, II or III. 18 active commercial programs & 9 in Phase III. USA, EU, Japan USFDA, PMDA > 95% of products manufactured serve these highly regulated markets. 100% successful track record of regulatory inspections across our R&D and manufacturing facilities. 7 of the top 10 big pharma companies as well as several small and medium biotechs utilize our services. First India-headquartered CDMO to join PSCI. 1st

RkJQdWJsaXNoZXIy MTIwMDc4NQ==